DISCLOSURE DIGEST
US insider purchases disclosed in week 2026-W41
2026-10-05 to 2026-10-11. 173 purchase disclosures at 81 companies by 135 buyers; reported value $791.5M.
- purchase disclosures
- 173
- companies
- 81
- buyers
- 135
- reported value
- $791.5M
Largest reported purchases by company
| Company | Ticker | Buyers | Disclosures | Reported value |
|---|---|---|---|---|
| LENNAR CORP /NEW/ | LEN | 2 | 2 | $385.3M |
| Keenova Therapeutics plc | NONE | 3 | 3 | $126.4M |
| BANK BRADESCO | BBD | 2 | 3 | $71.4M |
| Corebridge Financial, Inc. | CRBG | 1 | 5 | $42.7M |
| Gogoro Inc. | GGR | 1 | 1 | $35.1M |
| 51Talk Online Education Group | COE | 1 | 1 | $32.3M |
| Borr Drilling Ltd | BORR | 1 | 3 | $18.0M |
| Bluerock Private Real Estate Fund | BPRE | 2 | 3 | $12.0M |
| Lifeway Foods, Inc. | LWAY | 5 | 5 | $10.8M |
| QVC Group, Inc. | QVCG | 3 | 3 | $10.4M |
| Pershing Square USA, Ltd. | PSUS | 1 | 1 | $9.6M |
| Anteris Technologies Global Corp. | AVR | 1 | 2 | $8.7M |
| AXIA Energia S.A. | AXIA3 | 1 | 1 | $5.3M |
| Accelevation Holdings Corp. | ACCV | 5 | 5 | $4.1M |
| SONIC AUTOMOTIVE INC | SAH | 1 | 4 | $3.8M |
| PROTHENA CORP PUBLIC LTD CO | PRTA | 1 | 2 | $2.7M |
| IRIDEX CORP | IRIX | 1 | 3 | $1.3M |
| NEIGHBORHOOD INTELLIGENCE, INC. | NXH | 1 | 1 | $1.0M |
| MEXICO FUND INC | MXF | 1 | 2 | $909.8k |
| Calamos Aksia Private Equity & Alternatives Fund | N.A. | 1 | 1 | $909.7k |
| Outset Medical, Inc. | OM | 1 | 1 | $870.3k |
| CAZ GP Stakes Growth Fund | 2 | 2 | $853.3k | |
| Calamos Aksia Hedged Strategies Fund | 1 | 1 | $792.8k | |
| Calamos Aksia Alternative Credit & Income Fund | 1 | 1 | $561.5k | |
| 83 Investment Group Income Fund | NONE | 1 | 1 | $500.0k |
Companies with two or more buyers
| Company | Ticker | Buyers | Disclosures | Reported value |
|---|---|---|---|---|
| TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | TSM | 30 | 30 | $121.5k |
| Lifeway Foods, Inc. | LWAY | 5 | 5 | $10.8M |
| Accelevation Holdings Corp. | ACCV | 5 | 5 | $4.1M |
| JEWETT CAMERON TRADING CO LTD | JCTC | 4 | 4 | $164 |
| Keenova Therapeutics plc | NONE | 3 | 3 | $126.4M |
| QVC Group, Inc. | QVCG | 3 | 3 | $10.4M |
| AgomAb Therapeutics NV | AGMB | 3 | 4 | $311.2k |
| CROSS TIMBERS ROYALTY TRUST | CRT | 3 | 3 | $262.7k |
| Lion Copper Corp. | LCU | 3 | 5 | $75.0k |
| Neuraxis, INC | NRXS | 3 | 3 | $12.3k |
| LENNAR CORP /NEW/ | LEN | 2 | 2 | $385.3M |
| BANK BRADESCO | BBD | 2 | 3 | $71.4M |
| Bluerock Private Real Estate Fund | BPRE | 2 | 3 | $12.0M |
| CAZ GP Stakes Growth Fund | 2 | 2 | $853.3k | |
| InMed Pharmaceuticals Inc. | INM | 2 | 4 | $143.1k |
| WILLAMETTE VALLEY VINEYARDS INC | WVVI | 2 | 3 | $38.3k |
| INTELLINETICS, INC. | INLX | 2 | 2 | $20.8k |
| AH Realty Trust, Inc. | AHRT | 2 | 2 | $17.9k |
| CITIZENS & NORTHERN CORP | CZNC | 2 | 2 | $6.5k |
By buyer role
| Buyer role | companies | Disclosures | Reported value |
|---|---|---|---|
| 10% Owner | 21 | 55 | $595.3M |
| Director | 31 | 46 | $144.4M |
| Chief Executive Officer | 16 | 21 | $37.9M |
| Officer | 3 | 3 | $9.7M |
| Other | 7 | 8 | $3.6M |
| See Remarks | 2 | 2 | $252.5k |
| Chief Financial Officer | 5 | 5 | $147.2k |
| Secretary of Issuer | 1 | 1 | $100.0k |
| VP | 1 | 16 | $56.9k |
| SVP | 1 | 5 | $20.6k |
| EVP and Co-COO | 1 | 2 | $10.7k |
| SVP and Deputy Co-COO | 1 | 2 | $9.4k |
| SVP and GC | 1 | 1 | $4.2k |
| VP and CIO | 1 | 1 | $3.5k |
| Controller | 1 | 1 | $2.5k |
| Executive VP, Specialty | 1 | 1 | $1.9k |
| CRO, CCO, CPO | 1 | 1 | $1.6k |
| Secretary and CCO | 1 | 1 | $1,000 |
| President | 1 | 1 | $101 |
Purchases are Form 4 open-market purchases (code P) of qualifying equity as classified by the site's US screening rules; grants, option exercises, gifts and derivatives are excluded. Values are as reported, in USD. No score or rank is used on this page.